A. M. Monro
Impact in
- Pharmacology top 0.5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Small Animals top 1%
- Animal testing and alternatives
Papers in
-
- Effects and risks of endocrine disrupting chemicals 8
- Toxic Organic Pollutants Impact 5
-
- Carcinogens and Genotoxicity Assessment 14
- Co-authors
- Peter J. Smith (1 shared paper)Allen H. Heller (1 shared paper)William M. Bracken (1 shared paper)Patrick D. Lilly (1 shared paper)Graham R. Betton (1 shared paper)Harry M. Olson (1 shared paper)Bruce M. Berger (1 shared paper)Michael A. Dorato (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (5 papers)Regulatory Toxicology and Pharmacology (5 papers)Toxicology (4 papers)Xenobiotica (3 papers)Cancer Letters (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
A. M. Monro
63 papers receiving 2.0k citations
A. M. Monro's Hit Papers
Peers
Comparison fields: 5 of 142
- Pharmacology 461
- Small Animals 292
- Hepatology 154
- Cancer Research 236
- Chemical Health and Safety 10
Countries citing papers authored by A. M. Monro
This map shows the geographic impact of A. M. Monro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. M. Monro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. M. Monro more than expected).
Fields of papers citing papers by A. M. Monro
This network shows the impact of papers produced by A. M. Monro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. M. Monro. The network helps show where A. M. Monro may publish in the future.
Co-authors
The 25 scholars most cited alongside A. M. Monro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals Hit paper breakdown → | 2000 | 1436 |
| 2 | 1975 | 61 | |
| 3 | 1995 | 45 | |
| 4 | 1986 | 40 | |
| 5 | 1982 | 31 | |
| 6 | 1992 | 27 | |
| 7 | How useful are chronic (life-span) toxicology studies in rodents in identifying pharmaceuticals that pose a carcinogenic risk to humans? | 1993 | 27 |
| 8 | 1974 | 27 | |
| 9 | 1980 | 27 | |
| 10 | 1990 | 25 | |
| 11 | 2000 | 23 | |
| 12 | 1966 | 22 | |
| 13 | 1993 | 22 | |
| 14 | 1996 | 22 | |
| 15 | 1958 | 22 | |
| 16 | 1958 | 21 | |
| 17 | 1973 | 20 | |
| 18 | 1994 | 20 | |
| 19 | 1969 | 19 | |
| 20 | 1963 | 19 |
About A. M. Monro
A. M. Monro is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research, Organic Chemistry, Pharmacology and Pharmacology, having authored 63 papers that have together received 2.2k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (14 papers), Drug Transport and Resistance Mechanisms (8 papers), Effects and risks of endocrine disrupting chemicals (8 papers), Pharmacogenetics and Drug Metabolism (7 papers), Metabolism and Genetic Disorders (5 papers), Toxic Organic Pollutants Impact (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Synthesis of Organic Compounds (4 papers). The work is most often cited by research in Pharmacology (461 citations), Small Animals (292 citations), Hepatology (154 citations), Cancer Research (236 citations) and Chemical Health and Safety (10 citations). A. M. Monro has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Peter J. Smith, Allen H. Heller, William M. Bracken, Patrick D. Lilly, Graham R. Betton, Harry M. Olson, Bruce M. Berger, Michael A. Dorato, Gerald J. Kolaja and Karluss Thomas. Their work appears in journals such as Journal of Medicinal Chemistry, Regulatory Toxicology and Pharmacology, Toxicology, Xenobiotica and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.